Physician profile
Jack D Burton
NPI 1700897121
$27,127.98
in general payments reported to CMS, 2019-2025
96 companies · $6,877 in 2025
The $6,877 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,232 · 2020: $2,179 · 2021: $3,725 · 2022: $3,639 · 2023: $3,441 · 2024: $4,034 · 2025: $6,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $2,560 · Education: $265 · Travel and Lodging: $207 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,153.88 |
| Consulting Fee | $2,560.00 |
| Education | $265.03 |
| Travel and Lodging | $207.20 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,067.25 | 2019-2025 | Piqray, Kisqali |
| Geron Corporation | $2,877.22 | 2025 | Imetelstat, Rytelo |
| E.R. Squibb & Sons, L.L.C. | $1,625.73 | 2019-2025 | Opdivo, Augtyro |
| Genentech USA, INC. | $1,391.51 | 2019-2025 | Tecentriq, Polivy, Phesgo |
| Astrazeneca Pharmaceuticals LP | $1,169.53 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Pfizer INC. | $1,073.55 | 2019-2025 | |
| Astellas Pharma US INC | $992.82 | 2019-2025 | Xtandi, Xospata, Vyloy |
| Janssen Biotech, INC. | $977.28 | 2019-2025 | Erleada, Talvey, Tecvayli |
| Merck Sharp & Dohme LLC | $950.63 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $845.05 | 2019-2025 | Injectafer, Enhertu, Datroway |
| Incyte Corporation | $778.42 | 2019-2025 | Jakafi, Monjuvi |
| Genzyme Corporation | $664.02 | 2019-2025 | |
| Amgen INC. | $635.67 | 2019-2025 | Evenity, Kyprolis, Prolia |
| Eisai INC. | $582.94 | 2020-2025 | |
| Exelixis INC. | $456.72 | 2019-2025 | Cabometyx |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $436.86 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Celgene Corporation | $412.61 | 2021-2025 | Reblozyl, Opdivo, Pomalyst |
| Glaxosmithkline, LLC. | $385.83 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Taiho Oncology, INC. | $356.85 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $356.52 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Abbvie INC. | $343.38 | 2020-2025 | Venclexta |
| Bayer Healthcare Pharmaceuticals INC. | $306.79 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $288.40 | 2019-2023 | Imbruvica |
| Tg Therapeutics, INC. | $279.76 | 2022 | |
| Seagen INC. | $278.54 | 2019-2023 | Tukysa |
| Janssen Pharmaceuticals, INC | $269.48 | 2019-2024 | Xarelto |
| Alexion Pharmaceuticals, INC. | $257.41 | 2019-2025 | Ultomiris |
| Karyopharm Therapeutics INC. | $240.76 | 2020-2025 | Xpovio |
| Gilead Sciences, INC. | $239.68 | 2021-2025 | Trodelvy |
| Kite Pharma, INC. | $218.26 | 2019-2025 | Yescarta |
| Emd Serono, INC. | $212.05 | 2019-2024 | Bavencio, Tepmetko |
| Adc Therapeutics America, INC. | $211.33 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.38 | 2019-2025 | Gilotrif |
| Array Biopharma INC | $179.54 | 2021-2025 | Mektovi, Braftovi, Lorbrena |
| Mirati Therapeutics, INC. | $157.01 | 2023 | Krazati |
| Ipsen Biopharmaceuticals, INC | $155.73 | 2019-2025 | Onivyde |
| Pharmacosmos Therapeutics INC. | $154.95 | 2021-2025 | Monoferric, Cosela |
| Servier Pharmaceuticals LLC | $153.82 | 2023-2025 | |
| Aveo Pharmaceuticals, INC. | $147.74 | 2022-2025 | |
| Kyowa Kirin, INC. | $138.56 | 2019-2024 | Poteligeo |
| Jazz Pharmaceuticals INC. | $129.38 | 2021-2025 | |
| Sobi, INC | $127.93 | 2022-2025 | |
| Azurity Pharmaceuticals, INC. | $124.14 | 2024-2025 | Danziten, Vivimusta |
| Tempus Ai, INC | $115.50 | 2024-2025 | Xt Cdx |
| Regeneron Healthcare Solutions, INC. | $110.68 | 2022-2025 | Libtayo |
| Epizyme, INC. | $95.77 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $92.57 | 2021-2024 | Givlaari |
| Tersera Therapeutics LLC | $91.10 | 2022-2025 | Quzyttir, Xermelo |
| Secura Bio, INC. | $87.28 | 2020 | |
| Morphosys, US INC. | $82.99 | 2021-2023 | Monjuvi |
| Springworks Therapeutics, INC. | $78.57 | 2024-2025 | Ogsiveo, Gomekli |
| Beigene USA, INC. | $75.59 | 2023-2025 | Brukinsa |
| Mylan Institutional INC. | $72.48 | 2019-2021 | |
| Dova Pharmaceuticals | $72.45 | 2019-2021 | |
| Recordati_rare_diseases_inc. | $70.17 | 2023-2025 | Sylvant, Panhematin |
| Acrotech Biopharma INC. | $69.95 | 2022-2024 | Beleodaq |
| Fennec Pharmaceuticals, INC. | $69.90 | 2024 | Pedmark |
| Lexicon Pharmaceuticals, INC. | $59.02 | 2019 | |
| Fresenius Kabi USA, LLC | $52.69 | 2024 | Stimufend |
| Eusa Pharma (US) LLC | $51.29 | 2022 | |
| Foundation Medicine, INC. | $50.53 | 2023 | |
| Pharmaessentia USA Corporation | $47.48 | 2022-2025 | Besremi |
| Deciphera Pharmaceuticals INC. | $45.32 | 2021-2023 | Qinlock |
| Beone Medicines USA, INC. | $43.39 | 2025 | Brukinsa, Tevimbra |
| Octapharma USA, INC. | $38.15 | 2024 | Panzyga |
| Caris Mpi, INC. | $37.98 | 2025 | Mi Cancer Seek |
| Stemline Therapeutics INC. | $37.17 | 2024 | Elzonris |
| Ge Healthcare | $37.00 | 2021-2022 | |
| Verastem, INC. | $36.40 | 2019 | |
| Coherus Oncology, INC. | $32.65 | 2020-2024 | |
| Novocure INC. | $31.71 | 2024-2025 | Optune Gio, Optune |
| Tesaro, INC. | $30.07 | 2019 | |
| Invivyd INC | $27.65 | 2025 | Pemgarda |
| Rigel Pharmaceuticals, INC. | $26.66 | 2024 | Tavalisse, Rezlidhia |
| Biocon Biologics INC | $25.68 | 2025 | Ogivri |
| Genmab U.S., INC. | $24.69 | 2025 | Epkinly |
| Global Blood Therapeutics, INC. | $24.03 | 2020 | |
| G1 Therapeutics, INC. | $23.03 | 2022 | |
| Immunogen, INC. | $22.50 | 2023 | Elahere |
| Myovant Sciences INC. | $22.28 | 2021 | |
| Cti Biopharma Corp. | $21.77 | 2023 | Vonjo |
| Celltrion USA INC. | $21.75 | 2024 | Vegzelma |
| Agios Pharmaceuticals, INC. | $21.67 | 2025 | Pyrukynd |
| Accord Healthcare, INC. | $20.65 | 2023 | |
| Fortovia Therapeutics, INC. | $19.80 | 2020 | |
| Cashflow Solutions, LLC | $19.49 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Progenics Pharmaceuticals, INC. | $18.87 | 2024 | |
| Dendreon Pharmaceuticals LLC | $18.20 | 2021 | |
| Aurobindo Pharma USA, INC. | $17.76 | 2020 | |
| Adaptive Biotechnologies Corporation | $16.55 | 2025 | Clonoseq |
| Braintree Laboratories, INC. | $16.37 | 2023 | Sutab |
| Organon LLC | $15.36 | 2023 | Ontruzant |
| Amag Pharmaceuticals, INC. | $15.24 | 2019 | |
| Syndax Pharmaceuticals, INC. | $15.18 | 2025 | |
| Puma Biotechnology, INC. | $12.89 | 2021 | |
| Tactile Systems Technology INC | $12.03 | 2020 |
Drugs and devices associated with these payments
Imetelstat $2,855Opdivo $422Xtandi $392Keytruda $386Enhertu $317Kisqali $310Lenvima $300Lynparza $292Talzenna $285Jaypirca $263Injectafer $256Verzenio $245Erleada $223Talvey $218Ibrance $210Pluvicto $208Imbruvica $204Cabometyx $192Jakafi $181Nubeqa $176Tukysa $176Ultomiris $168Tecvayli $163Orgovyx $161Xpovio $160Krazati $157Elrexfio $150Mektovi $149Braftovi $149Xarelto $148Imfinzi $144Jemperli $141Zejula $141Xofigo $132Inlyta $127Sarclisa $125Padcev $124Reblozyl $124Calquence $122Epkinly $120Trodelvy $115Tibsovo $113Danziten $110Vonjo $105Rybrevant $104Fruzaqla $103Adcetris $103Jevtana $100Brukinsa $98.96Monjuvi $98.55Darzalex $94.69Bosulif $93.72Tecentriq $90.11Fotivda $88.49Scemblix $83.92Comirnaty $83.88Venclexta $81.55Paxlovid $81.44Iclusig $80.88Xospata $80.25Evenity $78.73Fabhalta $77.85Lutathera $77.17Lorbrena $76.21Polivy $74.51Carvykti $70.22Pedmark $69.90Phesgo $69.42Retevmo $65.64Stivarga $64.28Bavencio $64.18Ojjaara $64.08Perjeta $62.38Lonsurf $61.59Inqovi $61.59Zepzelca $61.05Piqray $59.31Datroway $55.61Columvi $54.87Lunsumio $54.87Stimufend $52.69Ogsiveo $52.59Sylvant $50.47Monoferric $50.37Givlaari $49.37Elahere $49.32Libtayo $49.24Cosela $47.23Alecensa $46.98Vyloy $45.21Gilotrif $44.86Quzyttir $44.75Beleodaq $44.14Besponsa $41.71Eliquis $41.16Panzyga $38.15Mi Cancer Seek $37.98Elzonris $37.17Kyprolis $36.49Yescarta $34.58
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.